MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2024 International Congress

September 27-October 1, 2024. Philadelphia, PA.

View by Title View Sessions
Jump to:  View All • a b c d e f g [h] i j k l m n o p q r s t u v w x y z
  • Habenular Structural Connectivity Changes in Parkinson’s Disease: A 7T MRI Study

    B. Samanci, A. Bayram, S. Tan, M. Wanders, M. Kuijf, Y. Temel (Maastricht, Netherlands)

  • Hand and Arm Function in Persons with De Novo Parkinson’s Disease

    B. Lindholm, LB. Dahlin, CH. Brogårdh, E. Franzen (Malmö, Sweden)

  • Handwriting Features in Patients with Isolated REM Sleep Behaviour Disorder

    R. Torricelli, J. Kenny, E. Bache, L. Pérez-Carbonell, B. Huxford, H. Chohan, G. Leschziner, A. Lees, A. Schrag, A. Noyce, C. Simonet (London, United Kingdom)

  • Haptics’ use in extended reality environments for Parkinson disease: A systematic review

    L. Ali, C. Lella, G. Giuliano, R. Di Fuccio (Napoli, Italy)

  • Harnessing chaperone-mediated autophagy through viral-based LAMP2A overexpression in non-human primates as a Treatment of Parkinson’s Disease

    ML. Arotcarena, M. Fouka, E. Gialinaki, L. Stefanis, E. Bezard, M. Xilouri, B. Dehay (BORDEAUX, France)

  • Health Care Utilization at the End-Of-Life in Parkinson´s Disease

    B. Leavy, E. åkesson, J. Lökk, T. Schultz, P. Strang, E. Franzén (Stockholm, Sweden)

  • Hemiparkinsonism Induction with 6-OHDA in Primates Does Not Induce SN Hyperechogenicity.

    L. Krejcova, W. Quaresma, L. Pedrosa, L. Leal, J. Muniz, B. Gomes (Belem, Brazil)

  • Hemochromatosis and Movement Disorders

    P J. Garcia Ruiz, C. Garcia Campos, C. Feliz, J. Del Val, J. Montoya (Torrelodones, Spain)

  • Hesperidin lessens rotenone induced Parkinson diseases angiogenesis in nigrostriatal neuronal death through the AMPK/FOXO3 Signaling pathway

    DS. Singh (Allahabad, India)

  • Heterogeneity of multiple system atrophy with an analysis of the clinical case

    M. Karzhaubayeva (Almaty, Kazakhstan)

  • Hierarchical Machine Learning Classification of Parkinsonian Disorders using Saccades

    O. Bredemeyer, S. Patel, J. Fitzgerald, C. Antoniades (Oxford, United Kingdom)

  • Higher Putamen Volume Asymmetry with Age-Preserved Volume in Isolated Adult-Onset Cervical Dystonia

    M. Owusu-Ansah, A. Tatenbaum, N. Goldman, SA. Norris (Saint Louis, USA)

  • Hippocampal volume in Parkinson’s Disease in south India

    R. Kandadai, T. Syed, A. Arora, T. Sd, S. Kola, S. Yaranagula, V. Prasad, R. Alugolu, S. Turaga, R. Borgohain (Hyderabad, India)

  • Holmes Tremor Treated with Pallidal Stimulation

    G. Genç, M. Kılıç, K. Kardelen Utangeç, D. Selçuk Demirelli, M. Müslüman (İstanbul, Turkey)

  • Hospital Care Learning Collaborative: Sharing strategies to address the Parkinson’s Foundation Inpatient Clinical Care Standards

    A. Brooks, E. Buetow, H. Azmi, B. Walter, K. Amodeo, P. Pronovost (Miami, USA)

  • How Botulinum Toxin Transformed the American Food Industry

    D. Riley (Cleveland Heights, USA)

  • How Common is Essential Tremor in Germany? A Real-World Claims Data Analysis

    JS. Becktepe, S. Müller, T. Wilke, E. Zhuleku, K. Appiah, K. Mcdonald, N. Dzimitrowicz, J. Marshall, J. Sabater, LM. Barbato, TA. Saifee (Kiel, Germany)

  • How Does Mild Cognitive Impairment in Parkinson’s Disease Affect Communication Abilities?

    F. Rodriguez-Porcel, T. Turner (Charleston, USA)

  • How does the PPP2R2B mutation alter neuronal cytoskeletal structure in SCA12

    A. Ganguly, B. Reddy, J. Rungta, S. Choudhury, R. Pal, H. Kumar, S. Chattarji (Kolkata, India)

  • How Local Field Potencial could improve GPi Deep Brain Stimulation programming in Tourette`s Syndrome – Case Report

    L. Barcelos, J. Salgado, M. Marinho (São Paulo, Brazil)

  • How many days are required to reliably estimate diverse digital mobility outcomes from various gait domains with a lower back sensor in people with Parkinson’s disease?

    E. Gazit, J. Garcia-Aymerich, J. Buekers, S. Del Din, A. Mueller, W. Maetzler, A. Yarnall, C. Schlenstedt, A. Nieuwboer, A. Mirelman, H. Gassner, D. Singleton, B. Vereijken, L. Rochester, JM. Hausdorff (Tel aviv, Israel)

  • Huntington’s Disease Pathogenesis, Molecular Factors, and Potential for Combinatorial Therapies: A Focus on BDNF and NMDA Receptor Therapies

    M. Mistry, J. Pace, E. Guivatchian, J. Hinman (Fort Worth, USA)

  • Hydrocephalic Progressive Supranuclear Palsy: An Underrecognized Entity

    A. Premkumar, D. Lim, SK. Seetharaman, LF. Tan (Singapore, Singapore)

  • Hyperkinetic Movements Related to COVID-19 Vaccine

    W. Abou Chaar, I. Xie, M. Padmanaban (Chicago, USA)

  • Hyposmia is Associated with Positive CSF α-Synuclein Seeding in Normal Pressure Hydrocephalus

    S. Weber, C. Farris, Y. Ma, M. Dakna, M. Starke, C. Trenkwalder, L. Concha-Marambio, B. Mollenhauer (Goettingen, Germany)

Jump to:  View All • a b c d e f g [h] i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley